Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Stomach Neoplasms 1 Prostatic Neoplasms 1 Neoplasms 1 Motor Activity 1 Liver Neoplasms 1 Liver Diseases 1

Interventions

lenvatinib 2 atezolizumab 2 Bevacizumab 2 Antibodies 2 sintilimab 1 pembrolizumab 1 camrelizumab 1 User-Centered Design 1 Standard of Care 1 Neuropsychological Tests 1 Neoadjuvant Therapy 1 Liver Transplantation 1 Lead 1 Injections 1 Control Groups 1 Catheter Ablation 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Liver Diseases × Lead × Clear all

NCT05931068 2024-08-05

PRO-NRG

Academisch Ziekenhuis Maastricht

Gastrointestinal

Liver Diseases, Liver Neoplasms, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡